-
1
-
-
0034769256
-
Life-threatening adverse events of antiepileptic drugs
-
Arroyo S, de la Morena A 2001) Life-threatening adverse events of antiepileptic drugs. Epilepsy Research 47 : 155 174.
-
(2001)
Epilepsy Research
, vol.47
, pp. 155-174
-
-
Arroyo, S.1
De La Morena, A.2
-
2
-
-
0029618012
-
Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
-
Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI 1995) Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46 : 355 367.
-
(1995)
Tissue Antigens
, vol.46
, pp. 355-367
-
-
Bunce, M.1
O'Neill, C.M.2
Barnardo, M.C.3
Krausa, P.4
Browning, M.J.5
Morris, P.J.6
Welsh, K.I.7
-
3
-
-
0021275561
-
Serum anticonvulsant concentrations and the risk of drug induced skin eruptions
-
Chadwick D, Shaw MD, Foy P, Rawlins MD, Turnbull DM 1984) Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. Journal of Neurolology, Neurosurgery and Psychiatry 47 : 642 644.
-
(1984)
Journal of Neurolology, Neurosurgery and Psychiatry
, vol.47
, pp. 642-644
-
-
Chadwick, D.1
Shaw, M.D.2
Foy, P.3
Rawlins, M.D.4
Turnbull, D.M.5
-
4
-
-
1842784823
-
Medical genetics: A marker for Stevens-Johnson syndrome
-
Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT 2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428 : 486.
-
(2004)
Nature
, vol.428
, pp. 486
-
-
Chung, W.H.1
Hung, S.I.2
Hong, H.S.3
Hsih, M.S.4
Yang, L.C.5
Ho, H.C.6
Wu, J.Y.7
Chen, Y.T.8
-
5
-
-
0342301745
-
Lamotrigine-associated rash: Risk/benefit considerations in adults and children
-
Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, Richens A, Stern RS, Trevathan E 1999) Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 40 : 985 991.
-
(1999)
Epilepsia
, vol.40
, pp. 985-991
-
-
Guberman, A.H.1
Besag, F.M.2
Brodie, M.J.3
Dooley, J.M.4
Duchowny, M.S.5
Pellock, J.M.6
Richens, A.7
Stern, R.S.8
Trevathan, E.9
-
6
-
-
33645082244
-
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
-
Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT 2006) Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenetics and Genomics 16 : 297 306.
-
(2006)
Pharmacogenetics and Genomics
, vol.16
, pp. 297-306
-
-
Hung, S.I.1
Chung, W.H.2
Jee, S.H.3
Chen, W.C.4
Chang, Y.T.5
Lee, W.R.6
Hu, S.L.7
Wu, M.T.8
Chen, G.S.9
Wong, T.W.10
Hsiao, P.F.11
Chen, W.H.12
Shih, H.Y.13
Fang, W.H.14
Wei, C.Y.15
Lou, Y.H.16
Huang, Y.L.17
Lin, J.J.18
Chen, Y.T.19
-
7
-
-
0001521392
-
On the bias of commonly used measures of association for 2x2 tables
-
Jewell NP 1986) On the bias of commonly used measures of association for 2x2 tables. Biometrics 42 : 351 358.
-
(1986)
Biometrics
, vol.42
, pp. 351-358
-
-
Jewell, N.P.1
-
8
-
-
33646934721
-
A marker for Stevens-Johnson syndrome ...: Ethnicity matters
-
RegiSCAR Group
-
Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt M, Roujeau JC, RegiSCAR Group 2006) A marker for Stevens-Johnson syndrome...: ethnicity matters. Pharmacogenomics Journal 6 : 265 268.
-
(2006)
Pharmacogenomics Journal
, vol.6
, pp. 265-268
-
-
Lonjou, C.1
Thomas, L.2
Borot, N.3
Ledger, N.4
De Toma, C.5
Lelouet, H.6
Graf, E.7
Schumacher, M.8
Hovnanian, A.9
Mockenhaupt, M.10
Roujeau, J.C.11
-
9
-
-
0344951264
-
Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones
-
Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK 2003) Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Molecular Pharmacology 63 : 732 741.
-
(2003)
Molecular Pharmacology
, vol.63
, pp. 732-741
-
-
Naisbitt, D.J.1
Britschgi, M.2
Wong, G.3
Farrell, J.4
Depta, J.P.5
Chadwick, D.W.6
Pichler, W.J.7
Pirmohamed, M.8
Park, B.K.9
-
10
-
-
7944234979
-
Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells
-
Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC 2004) Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. Journal of Allergy and Clinical Immunology 114 : 1209 1215.
-
(2004)
Journal of Allergy and Clinical Immunology
, vol.114
, pp. 1209-1215
-
-
Nassif, A.1
Bensussan, A.2
Boumsell, L.3
Deniaud, A.4
Moslehi, H.5
Wolkenstein, P.6
Bagot, M.7
Roujeau, J.C.8
-
12
-
-
0030749007
-
Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study
-
Tennis P, Stern RS 1997) Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 49 : 542 546.
-
(1997)
Neurology
, vol.49
, pp. 542-546
-
-
Tennis, P.1
Stern, R.S.2
-
13
-
-
33745672091
-
Activation of T cells by carbamazepine and carbamazepine metabolites
-
Wu Y, Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, Berry N, Stachulski AV, Clarke SE, Pichler WJ, Pirmohamed M, Park BK, Naisbitt DJ 2006) Activation of T cells by carbamazepine and carbamazepine metabolites. Journal of Allergy and Clinical Immunology 118 : 233 241.
-
(2006)
Journal of Allergy and Clinical Immunology
, vol.118
, pp. 233-241
-
-
Wu, Y.1
Sanderson, J.P.2
Farrell, J.3
Drummond, N.S.4
Hanson, A.5
Bowkett, E.6
Berry, N.7
Stachulski, A.V.8
Clarke, S.E.9
Pichler, W.J.10
Pirmohamed, M.11
Park, B.K.12
Naisbitt, D.J.13
|